Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-06

FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for IRBESARTAN from Camber Pharmaceuticals for the generic irbesartan product, indicating an approved modification relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)